23 min listen
Coronavirus (COVID-19) Update: Chloroquine/Hydroxychloroquine and Azithromycin
Coronavirus (COVID-19) Update: Chloroquine/Hydroxychloroquine and Azithromycin
ratings:
Length:
17 minutes
Released:
Mar 24, 2020
Format:
Podcast episode
Description
Chloroquine was shown in 2004 to be active in vitro against SARS coronavirus but is of unproven efficacy and safety in patients infected with SARS-CoV-2. The drug's potential benefits and risks for COVID-19 patients, without and with azithromycin, is discussed by Dr. David Juurlink, head of the Division of Clinical Pharmacology and Toxicology at Sunnybrook Health Sciences Centre in Toronto.
Released:
Mar 24, 2020
Format:
Podcast episode
Titles in the series (100)
Posttraumatic Stress Disorder: Edward H. Livingston, MD, interviews a war veteran and discusses PTSD with Maria Steenkamp, PhD, author of , and Michele Spoont, PhD, author of The article by Dr Steenkamp reports that many military personnel and veterans with posttraumatic stress... by JAMA Clinical Reviews